Richard Bryant Patchett
Physician at Briarwood, Marshfield, WI

License number
Colorado 26536
Issued Date
Jan 10, 1985
Renew Date
May 31, 1991
Expiration Date
May 31, 1991
Type
Physician
Address
Address
1206 Briarwood St, Marshfield, WI 54449

Professional information

Richard B Patchett Photo 1

Dr. Richard B Patchett, Marshfield WI - MD (Doctor of Medicine)

Specialties:
Ophthalmology
Address:
Marshfield Office
1000 N Oak Ave, Marshfield 54449
(715) 389-5900 (Phone)
Certifications:
Ophthalmology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Marshfield Office
1000 N Oak Ave, Marshfield 54449
Ministry Saint Joseph's Hospital
611 North Saint Joseph Ave, Marshfield 54449
Ministry Saint Michael's Hospital
900 Illinois Ave, Stevens Point 54481
Education:
Medical School
Loma Linda University
Graduated: 1983
L a Co Usc Med Center
University Louisville School Of Med
University Of Co School Of Med


Richard Bryant Patchett Photo 2

Richard Bryant Patchett, Marshfield WI

Specialties:
Ophthalmologist
Address:
1000 N Oak Ave, Marshfield, WI 54449
Education:
Loma Linda University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology


Richard Patchett Photo 3

Richard Patchett, Marshfield WI

Work:
Marshfield Clinic Marshfield
1000 N Oak Ave, Marshfield, WI 54449


Richard Patchett Photo 4

Adrb2 Gene Polymorphism Associated With Intraocular Pressure Response To Topical Beta-Blockers

US Patent:
2011025, Oct 13, 2011
Filed:
Jun 23, 2011
Appl. No.:
13/166845
Inventors:
Catherine Anne McCarty - Marshfield WI, US
James K. Burmester - Marshfield WI, US
Bickol N. Mukesh - Mansfield TX, US
Richard B. Patchett - Marshfield WI, US
Russell Alan Wilke - Brookfield WI, US
Assignee:
Marshfield Clinic - Marshfield WI
International Classification:
A61K 31/5377, C12Q 1/68, A61K 31/4704, A61P 27/06, A61K 31/138, A61K 31/222
US Classification:
5142362, 514652, 514546, 514312, 435 611
Abstract:
The invention provides a single nucleotide polymorphism (SNP) rs1042714 in the human ADRB2 gene (Gln27Glu) associated with a clinically meaningful reduction in intraocular pressure (IOP) in a human following treatment with a topical beta-blocker. Nucleic acids comprising the SNP are used to screen glaucoma-afflicted individuals to thereby provide an improved method for genotype-based prescribing of beta-blockers in glaucoma management.


Richard Patchett Photo 5

Adrb2 Gene Polymorphism Associated With Intraocular Pressure Response To Topical Beta-Blockers

US Patent:
2009029, Dec 3, 2009
Filed:
May 29, 2009
Appl. No.:
12/474441
Inventors:
Catherine Anne McCarty - Marshfield WI, US
James K. Burmester - Marshfield WI, US
Bickol N. Mukesh - Mansfield TX, US
Richard B. Patchett - Marshfield WI, US
Russell Alan Wilke - Brookfield WI, US
International Classification:
A61K 31/498, C12Q 1/68, A61K 31/138, A61P 27/06
US Classification:
514249, 435 6, 514651
Abstract:
The invention provides a single nucleotide polymorphism (SNP) rs1042714 in the human ADRB2 gene (Gln27Glu) associated with a clinically meaningful reduction in intraocular pressure (IOP) in a human following treatment with a topical beta-blocker. Nucleic acids comprising the SNP are used to screen glaucoma-afflicted individuals to thereby provide an improved method for genotype-based prescribing of beta-blockers in glaucoma management.